Page 108 - Functional impairment and cues for rehabilitation of head and neck cancer patients -

106
Chapter 4
23. van der Molen L, van Rossum MA, Ackerstaff AH, et al. Pretreatment organ function in patients with advanced head and neck cancer: clinical outcome measures and patients’ views. BMC Ear Nose Throat Disord. 2009;9:10.
24. Goepfert RP, Lewin JS, Barrow MP, et al. Grading Dysphagia as a Toxicity of Head and Neck Cancer: Differences in Severity Classification Based on MBS DIGEST and Clinical CTCAE Grades. Dysphagia. 2018;33(2):185-91.
25. Hutcheson KA, Barrow MP, Barringer DA, et al. Dynamic Imaging Grade of Swallowing Toxicity (DIGEST): Scale development and validation. Cancer. 2017;123(1):62-70.
26. Rosenbek JC, Robbins JA, Roecker EB, Coyle JL, Wood JL. A penetration-aspiration scale. Dysphagia. 1996;11(2):93-8.
27. Crary MA, Mann GD, Groher ME. Initial psychometric assessment of a functional oral intake scale for dysphagia in stroke patients. Arch Phys Med
Rehabil. 2005;86(8):1516-20.
28. Jensen MP, Chen C, Brugger AM. Interpretation of visual analog scale ratings and change scores: a reanalysis of two clinical trials of postoperative
pain. J Pain. 2003;4(7):407-14.
29. Kraaijenga SA, Oskam IM, van der Molen L, et al. Evaluation of long term (10-years+) dysphagia and trismus in patients treated with concurrent
chemo-radiotherapy for advanced head and neck cancer. Oral oncology. 2015;51(8):787-94.
30. van der Geer SJ, van Rijn PV, Kamstra JI, Roodenburg JLN, Dijkstra PU. Criterion for trismus in head and neck cancer patients: a verification study.
Support Care Cancer. 2019;27(3):1129-37.
31. Jager-Wittenaar H, Dijkstra PU, Vissink A, van Oort RP, Roodenburg JL. Variation in repeated mouth-opening measurements in head and neck
cancer patients with and without trismus. Int J Oral Maxillofac Surg. 2009;38(1):26-30.
32. ASISTO expert system. available at http://asistoelisugentbe/.
33. Middag C, Clapham R, Van Son R, Martens J-P. Robust automatic intelligibility assessment techniques evaluated on speakers treated for head and
neck cancer. Computer Speech & Language. 2014;28(2):467-82.
34. Maryn Y, De Bodt M, Barsties B, Roy N. The value of the acoustic voice quality index as a measure of dysphonia severity in subjects speaking
different languages. European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological
Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery. 2014;271(6):1609-19.
35. Barsties B, Maryn Y. The improvement of internal consistency of the Acoustic Voice Quality Index. Am J Otolaryngol. 2015;36(5):647-56.
36. Rinkel RN, Verdonck-de Leeuw IM, Langendijk JA, et al. The psychometric and clinical validity of the SWAL-QOL questionnaire in evaluating
swallowing problems experienced by patients with oral and oropharyngeal cancer. Oral oncology. 2009;45(8):e67-71.
37. McHorney CA, Robbins J, Lomax K, et al. The SWAL-QOL and SWAL-CARE outcomes tool for oropharyngeal dysphagia in adults: III. Documentation
of reliability and validity. Dysphagia. 2002;17(2):97-114.
38. Rinkel RN, Verdonck-de Leeuw IM, Doornaert P, et al. Prevalence of swallowing and speech problems in daily life after chemoradiation for head and
neck cancer based on cut-off scores of the patient-reported outcome measures SWAL-QOL and SHI. European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino- Laryngology - Head and Neck Surgery. 2016;273(7):1849-55.
39. Rinkel RN, Verdonck-de Leeuw IM, van Reij EJ, Aaronson NK, Leemans CR. Speech Handicap Index in patients with oral and pharyngeal cancer: better understanding of patients’complaints. Head Neck. 2008;30(7):868-74.
40. Dwivedi RC, St Rose S, Chisholm EJ, et al. Evaluation of speech outcomes using English version of the Speech Handicap Index in a cohort of head and neck cancer patients. Oral oncology. 2012;48(6):547-53.
41. Jacobson BH, Johnson A, Grywalski C, et al. The Voice Handicap Index (VHI)Development and Validation. American Journal of Speech-Language Pathology. 1997;6(3):66-70.
42. Verdonck-de Leeuw IM, Kuik DJ, De Bodt M, et al. Validation of the voice handicap index by assessing equivalence of European translations. Folia phoniatrica et logopaedica : official organ of the International Association of Logopedics and Phoniatrics (IALP). 2008;60(4):173-8.
43. Van Gogh CD, Mahieu HF, Kuik DJ, et al. Voice in early glottic cancer compared to benign voice pathology. European archives of oto-rhino- laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery. 2007;264(9):1033-8.
44. Leow LP, Huckabee ML, Anderson T, Beckert L. The impact of dysphagia on quality of life in ageing and Parkinson’s disease as measured by the swallowing quality of life (SWAL-QOL) questionnaire. Dysphagia. 2010;25(3):216-20.
45. Logemann JA, Curro FA, Pauloski B, Gensler G. Aging effects on oropharyngeal swallow and the role of dental care in oropharyngeal dysphagia. Oral diseases. 2013;19(8):733-7.
46. Ackerstaff AH, Rasch CR, Balm AJ, et al. Five-year quality of life results of the randomized clinical phase III (RADPLAT) trial, comparing concomitant intra-arterial versus intravenous chemoradiotherapy in locally advanced head and neck cancer. Head Neck. 2012;34(7):974-80.
47. Ackerstaff AH, Balm AJ, Rasch CR, et al. First-year quality of life assessment of an intra-arterial (RADPLAT) versus intravenous chemoradiation phase III trial. Head Neck. 2009;31(1):77-84.
48. Machtay M, Moughan J, Trotti A, et al. Factors associated with severe late toxicity after concurrent chemoradiation for locally advanced head and neck cancer: an RTOG analysis. J Clin Oncol. 2008;26(21):3582-9.
49. Rutten H, Pop LA, Janssens GO, et al. Long-term outcome and morbidity after treatment with accelerated radiotherapy and weekly cisplatin for locally advanced head-and-neck cancer: results of a multidisciplinary late morbidity clinic. International journal of radiation oncology, biology, physics. 2011;81(4):923-9.